The Fondation Recherche Alzheimer is raffling off a Picasso painting worth over $1 million to fund groundbreaking research into Alzheimer’s disease. The campaign, titled “1 Picasso Pour 100 Euros,” offers 120,000 tickets at €100 each (approximately $115–$117 USD) with a drawing scheduled for April 14, 2026, at Christie’s Paris. The $14 million target represents an ambitious commitment to advancing Alzheimer’s research—money that will directly support scientists investigating disease mechanisms, developing new treatments, and improving the daily lives of patients and families affected by this devastating neurological condition. This article explores the raffle’s details, what makes this fundraising approach unique, and why supporting Alzheimer’s research matters now more than ever.
Table of Contents
- What Is the Picasso Artwork Being Raffled?
- The Scale of the Raffle and Historical Precedent
- How Alzheimer’s Research Funding Makes a Difference
- How to Participate and the Drawing Process
- The Lottery Consideration and What You Should Know
- Picasso’s Legacy and Connection to Medical Causes
- The Future of Alzheimer’s Research and Funding Innovation
- Conclusion
What Is the Picasso Artwork Being Raffled?
The focal point of this raffle is “Tête de femme” (Head of a Woman), a 1941 gouache on paper that stands as one of picasso‘s celebrated works. The painting portrays Dora Maar, a French photographer and one of Picasso’s most well-known muses, who inspired numerous works throughout their relationship.
Valued at more than $1 million, this piece represents not merely a financial prize but a connection to one of the 20th century’s most influential artists. The work captures a critical period in Picasso’s career—1941 was during the German occupation of France, a time when the artist remained in Paris and continued creating despite significant social and political upheaval. For the winner, acquiring this painting would mean joining a small group of collectors who own authenticated Picasso works, an achievement that transcends personal gain given that the entire enterprise benefits medical research.
The Scale of the Raffle and Historical Precedent
This is the third major Picasso raffle launched by the Fondation Recherche Alzheimer, a pattern that demonstrates both the foundation’s success with this fundraising model and their strategic vision for generating substantial research funding. In 2013, a raffle featuring Picasso’s “L’Homme au Gibus” (1914) raised €5 million, with proceeds directed to UNESCO’s efforts to preserve the heritage site of Tyre in Lebanon. Seven years later, in 2020, another Picasso raffle—this time offering “Nature Morte” (1921)—generated another €5 million, funding CARE’s clean water and hygiene programs in developing regions.
The current raffle aims to raise €12 million ($14 million USD), setting a notably higher target than the previous campaigns. This escalation reflects both increased ambition and confidence in the model’s appeal. However, setting an ambitious goal carries inherent risks: if ticket sales fall short of projections, the final fundraising total may not reach the stated €12 million target, which is an important consideration for supporters who want assurance their contribution will meet specific research milestones.
How Alzheimer’s Research Funding Makes a Difference
The €12 million raised by this raffle will be allocated across three critical domains of Alzheimer’s research. First, funds support investigations into the disease’s underlying mechanisms—the cellular and molecular processes that drive neurodegeneration. Second, the money finances development programs aimed at bringing new treatments and therapeutic approaches closer to clinical reality.
Third, and importantly for current patients and caregivers, portions of the funding support initiatives focused on improving quality of life, including interventions that reduce caregiver burden, enhance cognitive support systems, and address the non-cognitive symptoms (such as behavioral changes and sleep disturbances) that often prove as challenging as memory loss itself. Unlike some medical fundraising campaigns that support a single research institution, the Fondation Recherche Alzheimer distributes funds across a network of researchers and clinics, broadening the impact and reducing the risk that a single project failure would waste donated resources. This diversified approach has proven effective: over the past decade, Alzheimer’s research has made measurable progress in early detection, with biomarker tests now available that can identify the disease years before symptoms appear—progress that would not have occurred without funding streams like those generated by these raffles.
How to Participate and the Drawing Process
Purchasing a ticket is straightforward for anyone interested in entering. Tickets cost €100 (approximately $115–$117 USD depending on exchange rates at the time of purchase), with 120,000 tickets available. The campaign launched in December 2025 and runs until April 14, 2026, when Christie’s Paris will conduct the official drawing.
For those unable to travel to Paris, ticket purchases can typically be completed through the foundation’s website or authorized partners, with the drawing being a public event that ensures transparency. The actual odds of winning stand at 1 in 120,000—approximately 0.0008%—which, while infinitesimally small from an individual perspective, is actually more favorable than many state lotteries in Europe and North America. Where this raffle differs from traditional lotteries is the guarantee that 100% of ticket revenue funds Alzheimer’s research, whereas state lotteries typically allocate only a fraction of revenue to their stated causes. If you’re considering purchasing a ticket, the comparison is worth noting: you’re trading a modest financial investment for the dual benefit of supporting meaningful medical research and entering a drawing with prizes more valuable than most lottery offerings.
The Lottery Consideration and What You Should Know
Before purchasing tickets, it’s worth acknowledging the realities of raffle participation. The odds of winning are extraordinarily low—one ticket among 120,000 represents a 0.0008% chance of success. For the vast majority of participants, the €100 will not result in owning a Picasso painting; instead, it becomes a donation to medical research.
This is not inherently a problem—many people consciously purchase raffle tickets as a form of charitable giving with a small lottery element attached—but it’s crucial to enter with realistic expectations rather than genuine hope of winning. Additionally, different countries have varying legal frameworks around raffles and lotteries, so individuals should verify that participation is legal in their jurisdiction. Those living in regions where lotteries are restricted or heavily regulated may face legal barriers to entry, and it’s important to check local regulations before purchasing. Some people also feel uncomfortable with gambling-adjacent activities on principle; if that applies to you, direct charitable donations to the Fondation Recherche Alzheimer offer the same research support without the raffle component.
Picasso’s Legacy and Connection to Medical Causes
The decision to feature a Picasso painting in this raffle represents a meaningful choice beyond mere marketing appeal. Picasso’s work has often been connected to humanitarian causes—his famous “Guernica” painting, created in response to the bombing of a Basque town during the Spanish Civil War, stands as perhaps the most iconic artwork addressing human suffering and the need for social change. While “Tête de femme” was created before that famous work, Picasso’s career consistently demonstrated awareness of the world beyond the studio.
By leveraging his artistic legacy for medical research, the Fondation Recherche Alzheimer taps into a tradition of using cultural treasures to address pressing human challenges. This approach also elevates public consciousness about Alzheimer’s—a disease that remains somewhat stigmatized or overlooked in mainstream conversation despite affecting millions worldwide—by pairing it with an unmistakably prestigious cultural artifact. The raffle thus becomes not just a fundraising mechanism but a cultural statement about the importance of neurodegenerative disease research.
The Future of Alzheimer’s Research and Funding Innovation
This raffle represents one example of how organizations are innovating fundraising strategies to address the substantial financial needs of medical research. Alzheimer’s disease affects an estimated 57 million people worldwide, and as populations age globally, that number is projected to triple by 2050. The current level of research funding, while growing, remains insufficient to meet the scale of the challenge.
Novel approaches like high-value art raffles help bridge this gap by appealing to both art collectors and general supporters who want to make a meaningful contribution. If this third Picasso raffle achieves or exceeds its €12 million goal, it may inspire similar campaigns by other research foundations—using cultural assets and celebrity partnerships to generate substantial funding in ways that traditional grant mechanisms and government allocations cannot match. The success of this model may signal a broader shift toward creative fundraising in medical research, where the mechanism itself becomes part of the story and public engagement.
Conclusion
The Picasso raffle launched by the Fondation Recherche Alzheimer represents an innovative approach to generating funding for urgent medical research. With 120,000 tickets available at €100 each, the campaign aims to raise €12 million to support Alzheimer’s research into disease mechanisms, new treatments, and quality-of-life improvements for patients and families.
Whether you view participation as a charitable donation with a lottery component or simply an interesting cultural moment, the raffle offers a concrete way to support research that could meaningfully impact millions of people affected by Alzheimer’s disease. If you’re interested in participating, the drawing occurs on April 14, 2026, at Christie’s Paris. Beyond the raffle itself, supporting Alzheimer’s research through direct donations to the Fondation Recherche Alzheimer or similar organizations remains an important way to advance our understanding of this disease and accelerate the development of effective treatments.
You Might Also Like
- Walk to End Alzheimer’s Events Launch Across the Country
- Scientists Map Brain Aging at Single-Cell Level With Alzheimer’s Clues
- Exercise Triggers Liver Enzyme That May Shield Against Alzheimer’s
For more, see Alzheimer’s Association.
